LONDON (AP) — The lead researcher of the Oxford-AstraZeneca vaccine says she expects to have a modified jab to cope with the South Africa coronavirus variant by the autumn. Health officials in Britain are trying to contain the spread of the variant first identified in South Africa, amid concerns that it is more contagious or resistant to existing vaccines. Sarah Gilbert, lead researcher for the Oxford team, told the BBC that “we have a version with the South African spike sequence in the works." Oxford University said Sunday that early data from a small study suggested that the current AstraZeneca vaccine offers “minimal protection” against mild disease caused by the South Africa variant.
Photo courtesy of Dominic Lipinski/PA via AP
The lead researcher of the Oxford-AstraZeneca vaccine says she expects to have a modified jab to cope with the South Africa coronavirus variant by the autumn.
Posted: Feb 7, 2021 9:41 AM
Updated: Feb 7, 2021 10:26 AM
- AstraZeneca vaccine being tweaked to fight S. Africa variant
- AstraZeneca's Covid-19 Vaccine Approved in the U.K.
- J&J says vaccine effective against Covid, though weaker against South Africa variant
- Oxford-AstraZeneca Covid-19 vaccine is safe, European Medicines Agency rules
- AstraZeneca: US data shows vaccine effective for all ages
- Virus variant from South Africa detected in US for 1st time
- Pfizer Says Vaccine Can Work Against Variants
- AstraZeneca vaccine appears to substantially reduce transmission of the coronavirus, study shows
- Ireland halts use of AstraZeneca vaccine following blood clot reports in Norway
- Canadian Panel Recommends AstraZeneca Pause for People Under 55
Scroll for more content...